-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
West Pharmaceutical Services Inc annual/quarterly Amortization of Intangible Assets history and growth rate from Q2 2020 to Q1 2022.
- West Pharmaceutical Services Inc Amortization of Intangible Assets for the quarter ending March 31, 2022 was $200K, unchanged year-over-year.
- West Pharmaceutical Services Inc annual Amortization of Intangible Assets for 2023 was $3.6M, a 2.7% decline from 2022.
- West Pharmaceutical Services Inc annual Amortization of Intangible Assets for 2022 was $3.7M, a 31.5% decline from 2021.
- West Pharmaceutical Services Inc annual Amortization of Intangible Assets for 2021 was $5.4M, a 22.7% increase from 2020.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)